LEXICON PHARMACEUTICALS, INC. (LXRX) › Capital ExpendituresLEXICON PHARMACEUTICALS, INC. (LXRX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $369.0K2010: $1.13M2011: $1.21M2012: $492.0K2013: $1.72M2014: $80.0K2015: $910.0K2016: $231.0K2017: $228.0K2018: $95.0K2019: $70.0K2020: $87.0K2021: $1.22M2022: $1.33M2023: $470.0K2024: $1.03M2025: $0$02009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$0-100.0%2024$1.03M+119.4%2023$470.0K-64.6%2022$1.33M+8.6%2021$1.22M+1303.4%2020$87.0K+24.3%2019$70.0K-26.3%2018$95.0K-58.3%2017$228.0K-1.3%2016$231.0K-74.6%2015$910.0K+1037.5%2014$80.0K-95.4%2013$1.72M+249.8%2012$492.0K-59.2%2011$1.21M+6.5%2010$1.13M+206.8%2009$369.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share